The true measurement of a presidential legacy escapes the superficial flash of state dinners and corporate expansions, finding its rhythm instead in the foundational realities of human welfare and hemispheric strategy. When looking at the Western Hemisphere, a dynamic statecraft utilizing incentives rather than coercion frequently termed carrot diplomacy must reckon with Cuba’s most potent instrument of international influence: its healthcare infrastructure. For decades, the island has operated an extraordinarily robust medical apparatus that serves as the structural backbone of the nation’s domestic stability and functions as its primary currency on the global stage.

Cuba‘s global footprint is fundamentally driven by its medical corps. Through the state-run program known as misiones médicas (medical missions), tens of thousands of healthcare professionals are deployed across Latin America, Africa, and the Caribbean. This strategy yields deep geopolitical dividends. The export of medical services functions as Cuba’s primary source of foreign currency, as hosting governments pay the Cuban state directly to provide vital financial liquidity that keeps the island’s domestic economy afloat. By sending clinicians to underserved rural areas where local doctors often refuse to go, Havana builds deep-seated goodwill among regular citizens and foreign heads of state alike. Furthermore, institutions like ELAM—the Escuela Latinoamericana de Medicina (Latin American School of Medicine) in Havana—train thousands of international students from low-income backgrounds for free, embedding a pro-Cuba medical network across the globe.

For a United States administration aiming to redefine hemispheric relations through engagement rather than the traditional stick of economic embargoes, Cuba’s medical apparatus presents both an opportunity and a complex ethical landscape. True diplomatic leverage is not built by imposing cultural icons or economic pressure, but by identifying and engaging with a nation’s organic engines of survival. Joint biomedical research offers one avenue of progress, as Cuba has developed unique biotech assets, including CIMAvax, a lung cancer immunotherapy. Collaborative FDA trials could offer massive public health breakthroughs for both nations. Cooperative agreements could also pair American logistical might with Cuban medical personnel to tackle systemic health crises, dengue outbreaks, and natural disasters in the Caribbean basin.

However, these opportunities coexist with deep systemic complications. Critics and international watchdogs argue that the medical missions exploit doctors by withholding the vast majority of their salaries and restricting their movement. Additionally, while the export system thrives, Cuba’s domestic hospitals frequently suffer from severe shortages of basic supplies, antibiotics, and working equipment due to a combination of economic mismanagement and the embargo. A legacy-defining foreign policy in the region requires looking past ideological blockades to address these realities directly. By treating Cuba’s medical capacity as a serious diplomatic touchpoint, policymakers shift the conversation from frozen Cold War theater to tangible, public-health-driven engagement.